Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

NEVRO CORP.

(A12EPL)
  Bericht
verzögerte Kurse. Verzögert Nyse - 22.10. 22:10:00
121.29 USD   +0.85%
06.10.NEVRO CORP. : OTR Global gibt eine neutrale Bewertung ab
MM
05.08.NEVRO CORP. : Vom Kauf zur neutralen Bewertung von Canaccord Genuity
MM
05.08.NEVRO CORP. : Citigroup ist neutral
MM
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über NEVRO CORP.
11.10.NEVRO : to Report Third Quarter 2021 Financial Results
31.08.NEVRO : Healthcare Executive and Industry Veteran Sri Kosaraju Joins the Board (Form 8-K)
31.08.NEVRO CORP : Change in Directors or Principal Officers, Other Events, Financial Statements..
31.08.NEVRO : Announces Director Appointment
31.08.Nevro Corp. Appoints Sri Kosaraju as Member of the Board of Directors
26.08.NEVRO : to Present at Baird 2021 Global Healthcare Conference
25.08.NEVRO : to Present at Morgan Stanley 19th Annual Global Healthcare Conference
23.08.NEVRO : to Present at Wells Fargo Virtual Healthcare Conference
17.08.INSIDER TRENDS : 90-Days of Insider Selling at Nevro Eased Back with Share Purchase
10.08.INSIDER TRENDS : Nevro Insider Sale for Taxes Adds to 90-Day Selling Trend
05.08.SECTOR UPDATE : Health Care Stocks Trim Losses Late
05.08.SECTOR UPDATE : Health Care Stocks Sliding Thursday While Biotechs Advance
05.08.NEVRO : Q2 Loss Narrows as Revenue Rises, Full-Year Guidance Withdrawn
05.08.Wall Street Wavers Pre-Bell; US Trade Gap Widens in June
04.08.NEVRO : Reports Second Quarter 2021 Financial Results and Provides Third Quarter of 2021 G..
04.08.NEVRO : Q2 Earnings Snapshot
04.08.NEVRO : Management's Discussion and Analysis of Financial Condition and Results of Operati..
04.08.Nevro Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021
04.08.NEVRO : Earnings Flash (NVRO) NEVRO Posts Q2 Revenue $102.3M, vs. Street Est of $102.8M
04.08.NEVRO CORP : Results of Operations and Financial Condition, Financial Statements and Exhib..
04.08.Nevro Corp. Provides Earnings Guidance for the Third Quarter 2021
04.08.Nevro Corp. Withdraws Full Year 2021 Guidance
19.07.NEVRO : Gets FDA Approval For Chronic Pain Treatment; Expects Q2 Revenue of $102.3 Million
19.07.NEVRO : Company Announces Preliminary, Unaudited Second Quarter 2021 Revenue of Approximat..
19.07.NEVRO CORP : Results of Operations and Financial Condition, Other Events, Financial Statem..
19.07.Nevro Corp. Provides Preliminary, Unaudited Revenue Guidance for the Second Quarter of ..
19.07.Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Thera..
07.07.NEVRO : to Report Second Quarter 2021 Financial Results
26.06.NEVRO : Insider at Nevro (NVRO) Makes Significant Sale of Stock
24.06.INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Nevro
23.06.INSIDER TRENDS : Insider at Nevro Continues Selling Trend with Tax Sale
22.06.Nevro Corp. Announces SENZA-NSRBP Clinical Data Presentation at the American Society of..
22.06.Nevro Corp. SENZA-PDN Clinical Data Presentation at the American Diabetes Association 8..
17.06.INSIDER TRENDS : Nevro Insider Makes Tax Sale Extends 90-Day Selling Trend
28.05.NEVRO CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
05.05.NEVRO : Q1 Earnings Snapshot
05.05.NEVRO : Management's Discussion and Analysis of Financial Condition and Results of Operati..
05.05.NEVRO : Earnings Flash (NVRO) NEVRO Posts Q1 Revenue $88.6M, vs. Street Est of $85.3M
05.05.NEVRO CORP : Results of Operations and Financial Condition, Financial Statements and Exhib..
05.05.NEVRO : Reports First Quarter 2021 Financial Results and Updates 2021 Guidance
05.05.Nevro Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021
05.05.Nevro Corp. Provides Earnings Guidance for the Second Quarter Ended June 30, 2021 and F..
27.04.NEVRO : to Present at UBS Global Healthcare Virtual Conference
26.04.NEVRO : Introduces HFX, New Comprehensive Brand Identity Combining Nevro's Innovative Tech..
26.04.Nevro Introduces HFX, New Comprehensive Brand Identity Combining Nevro's Innovative Tec..
19.04.NEVRO : Appoints Jon R. Shear as Vice President, Corporate Development
19.04.Nevro Corp. Appoints Jon R. Shear as Vice President of Corporate Development
13.04.INSIDER TRENDS : Nevro Insider Makes Shares Sale for Tax Slowing 90-Day Buy Trend
13.04.NEVRO : to Present at BofA Securities 2021 Virtual Health Care Conference
07.04.NEVRO : to Report First Quarter 2021 Financial Results
05.04.NEVRO : Trial of Senza Spinal Cord Stimulation System Meets Primary Endpoint
05.04.NEVRO : Investor Presentation – Apr 5, 2021
05.04.Nevro Announces Publication of Landmark SENZA-PDN Clinical Trial Results in Jama Neurol..
23.03.INSIDER TRENDS : Insider at Nevro Makes Tax Sale Interrupting 90-Day Buy Trend
16.03.NEVRO : Investor Presentation – Feb 24, 2021
24.02.NEVRO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATI..
24.02.NEVRO : Q4 Loss Narrows as Revenue Slips; Sets Revenue Outlook Below Estimates; Shares Dow..
24.02.NEVRO : 4Q Earnings Snapshot
24.02.NEVRO CORP : Results of Operations and Financial Condition, Financial Statements and Exhib..
24.02.Nevro Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
24.02.NEVRO : Earnings Flash (NVRO) NEVRO Reports Q4 Revenue $94.6M, vs. Street Est of $107.4M
24.02.Nevro Corp. Provides Earnings Guidance for the First Quarter and Full Year of 2021
01.02.NEVRO : to Present at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conf..
01.02.NEVRO : to Present at 10th Annual SVB Leerink Global Healthcare Conference
27.01.NEVRO : to Report Fourth Quarter and Full-Year 2020 Financial Results
14.01.Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Soc..
11.01.NEVRO : Pre-Announces Decline in Q4 Revenue That Beats Analysts' Expectations
11.01.NEVRO CORP : Results of Operations and Financial Condition, Financial Statements and Exhib..
11.01.NEVRO : Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2020 Revenue
11.01.Nevro Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year 2020
05.01.INSIDER TRENDS : Nevro Insider Tax Sale Continues 90-Day Selling Trend
2020NEVRO : Seeks US FDA OK of HF10 Therapy for Painful Diabetic Neuropathy
2020Nevro Corp. Announces FDA Submission for HF10 Therapy
2020INSIDER TRENDS : Insider at Nevro Sale for Taxes Adds to 90-Day Selling Trend
2020NEVRO : to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12..
1  2  3  4  5Weiter
Anstehende Termine für NEVRO CORP.
08.11.21